Cargando…
Co-crystallisation and humanisation of an anti-HER2 single-domain antibody as a theranostic tool
Human epidermal growth factor receptor-2 (HER2) is a well-recognised biomarker associated with 25% of breast cancers. In most cases, early detection and/or treatment correlates with an increased chance of survival. This study, has identified and characterised a highly specific anti-HER2 single-domai...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10351726/ https://www.ncbi.nlm.nih.gov/pubmed/37459326 http://dx.doi.org/10.1371/journal.pone.0288259 |